2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.
Hur Kyu Yeon, Moon Min Kyong, Park Jong Suk, Kim Soo-Kyung, Lee Seung-Hwan, Yun Jae-Seung, Baek Jong Ha, Noh Junghyun, Lee Byung-Wan, Oh Tae Jung, Chon Suk, Yang Ye Seul, Son Jang Won, Choi Jong Han, Song Kee Ho, Kim Nam Hoon, Kim Sang Yong, Kim Jin Wha, Rhee Sang Youl, Lee You-Bin, Jin Sang-Man, Kim Jae Hyeon, Kim Chong Hwa, Kim Dae Jung, Chun SungWan, Rhee Eun-Jung, Kim Hyun Min, Kim Hyun Jung, Jee Donghyun, Kim Jae Hyun, Choi Won Seok, Lee Eun-Young, Yoon Kun-Ho, Ko Seung-Hyun, Committee of Clinical Practice Guidelines, Korean Diabetes Association
Diabetes & metabolism journal · 2021 · PMID 34352984 · 인용 226
The Committee of Clinical Practice Guidelines of the Korean Diabetes Association (KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and prediabetes and published the seventh edition in May 2021. We performed a comprehensive systematic review of recent clinical trials and evidence that could be applicable in real-world practice and suitable for the Korean population. The guideline is provided for all healthcare providers including physicians, diabetes experts, and certified diabetes educators across the country who manage patients with diabetes or the individuals at the risk of developing diabetes mellitus.
The recommendations for screening diabetes and glucose-lowering agents have been revised and updated. New sections for continuous glucose monitoring, insulin pump use, and non-alcoholic fatty liver disease in patients with diabetes mellitus have been added. The KDA recommends active vaccination for coronavirus disease 2019 in patients with diabetes during the pandemic.
An abridgement that contains practical information for patient education and systematic management in the clinic was published separately.